Efficacy of a Nurse-based Intervention on Tobacco Consumption in Hospitalized Patients (HOT)

Tobacco consumption is a major public health problem, ranking second in the leading cause of morbidity and mortality worldwide, in 2010. The prevalence of tobacco smoking in hospitalized patients is evaluated around 20% and the management of tobacco reduction/cessation is an major issue for the course and outcome of many disorders.

Recent recommendations published by the French National Health Authority ("Haute Autorité de Santé", HAS) call for the involvement of all health professionals in helping patients to stop smoking and hospitalized patients are identified as a specific target. In addition, the meta-analysis of Rigotti et al. (2012) showed that the most effective programs (tobacco cessation) were those that include all patients, starting during the hospitalization with a specific follow-up of at least one month, and with the addition of nicotine replacement therapy. This combination increased the odds of successful tobacco cessation by 54%.

The project aims to evaluate the short-term efficacy (1 month) of a nurse-based program on tobacco smoking consumption in a population of hospitalized patients.

Study Overview

• Status: Unknown
• Conditions: Smoking Patients
• Intervention / Treatment: Other: Tobacco management

• Study Type: Observational
• Enrollment (Actual): 430

Contacts and Locations

Study Locations

• France
  • Paris, France, 75010
    • Fernand Widal Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

All smoking patients hospitalized in one of the participating unit of the Saint-Louis-Lariboisière-Fernand Widal hospital (Diabetology, Cardiology, adults and adolescents Onco-hématology, Orthopedy, Oncology, Internal Medecine, Pneumology, Dermatology, Rhumatology, Psychiatry, Gastro-Entérology, Neurology) during the study period that include the 6 months preceding and the 6 months following the training.

Description

Inclusion Criteria:

• Adult patient (>= 18 years), tobacco smokers, hospitalized in one of the participating unit during the inclusion period.
• For the sake of coherence with the literature, only subjects who smoked at least one cigarette a day in the previous 30 days before the hospitalization will be considered as "smokers".
• Affiliated to the national health system
• Signed informed consent

Exclusion Criteria:

• Patients enrolled in an addiction treatment during their hospitalization stay
• Cognitive deficit that makes the informed consent and the telephone interview impossible
• Aphasia
• Patient who does not speak French
• Life expectancy below 6 months

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
1 month tobacco smoking prevalence	1 month

Secondary Outcome Measures

Outcome Measure	Time Frame
6 month tobacco smoking prevalence	6 months

Collaborators and Investigators

• Sponsor: Assistance Publique - Hôpitaux de Paris

Study record dates

Study Major Dates

• Study Start (Actual): November 1, 2017
• Primary Completion (Actual): June 1, 2020
• Study Completion (Anticipated): January 1, 2021

Study Registration Dates

• First Submitted: September 11, 2017
• First Submitted That Met QC Criteria: September 11, 2017
• First Posted (Actual): September 13, 2017

Study Record Updates

• Last Update Posted (Actual): November 20, 2020
• Last Update Submitted That Met QC Criteria: November 19, 2020
• Last Verified: November 1, 2020

More Information

Terms related to this study

• Other Study ID Numbers: HAO16020

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No